Search or

𝛼SK

ENTITY

Duality Biotherapeutics (9606 HK)

49

Analysis

Health Care • Hong Kong

Duality Biotherapeutics, Inc. develops antibody drug conjugate products. The Company produces duality immune toxin antibody conjugates, duality innovative bispecific antibody conjugates, modulating antibody conjugates, duality unique payload antibody conjugates, and others. Duality Biotherapeutics markets its products throughout Japan.

more

Refresh

Exchange Announcement • 17 Oct 2025 18:11

Inside Information - Proposed Issue Of Rmb Shares And Listing On The Sci-Tech Board Of The Shanghai Stock Exchange

Exchange Announcement • 17 Sep 2025 22:00

2025 Interim Report

Exchange Announcement • 07 Sep 2025 18:44

Voluntary Announcement - Inclusion As A Constituent Of Hang Seng Composite Index And Inclusion In The Stock List Of Stock Connect Southbound Trading Link

Exchange Announcement • 05 Sep 2025 17:07

Inside Information - Primary Endpoint Met For Phase Iii Clinical Trial Of Db-1303/Bnt323 In Patients With Her2-Positive Unresectable Or Metastatic Breast Cancer

Exchange Announcement • 26 Aug 2025 17:32

Interim Results Announcement For The Six Months Ended June 30, 2025

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.59.7

x